- CA$364.09m
- CA$392.88m
- CA$38.97m
- 51
- 14
- 59
- 36
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.7 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 9.34 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -27.61% | ||
| Return on Equity | -68.57% | ||
| Operating Margin | -72.4% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 38.57 | 47.82 | 10.42 | 7.32 | 38.97 | 145.37 | 207.31 | -3.38% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Healwell Al Inc. is a Canada-based healthcare artificial intelligence (AI) company focused on preventative care. The Company, using its own proprietary technology, is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases. The Company's segments include Clinical Research and Patient services, AI and Data sciences and Healthcare Software. The Clinical Research and Patient Services segment includes clinical research contracts and medical consultations provided through the Company's MCI Polyclinic Group Inc. and BioPharma subsidiaries in Ontario. The AI and Data Sciences segment includes integration of advanced AI and data science technologies in healthcare through its Khure Health Inc. and Pentavere divisions. The Company's AutoScribe platform is an advanced AI-powered ambient scribe solution. The Healthcare Software segment includes Intrahealth and Versource healthcare software-as-a-service.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 30th, 2020
- Public Since
- April 25th, 2007
- No. of Employees
- 350
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Toronto Stock Exchange- Shares in Issue
- 249,377,508
- Address
- 4881 Yonge Street, Suite 300, Toronto, M2N5X3
- Web
- https://healwell.ai/
- Phone
- +1 9059606717
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for AIDX
Healwell Al Inc Annual Shareholders Meeting
Q2 2025 Healwell Al Inc Earnings Release
Similar to AIDX
Bausch + Lomb
Toronto Stock Exchange
Profound Medical
Toronto Stock Exchange
Sernova Biotherapeutics
Toronto Stock Exchange
Vitalhub
Toronto Stock Exchange
FAQ
What is the Healwell Al share price?
As of Today at 21:03 UTC, shares in Healwell Al are trading at CA$1.46. This share price information is delayed by 15 minutes.
How has the Healwell Al share price performed this year?
Shares in Healwell Al last closed at CA$1.46 and the price had moved by -5.81% over the past 365 days. In terms of relative price strength the Healwell Al share price has underperformed the Toronto Stock Exchange 300 Composite Index by -16.26% over the past year.
What are the analyst and broker recommendations for Healwell Al?
The overall consensus recommendation for Healwell Al is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Healwell Al dividend yield?
Healwell Al does not currently pay a dividend.
Does Healwell Al pay a dividend?
Healwell Al does not currently pay a dividend.
When does Healwell Al next pay dividends?
Healwell Al does not currently pay a dividend.
How do I buy Healwell Al shares?
To buy shares in Healwell Al you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Healwell Al?
As of the previous close price of CA$1.46, shares in Healwell Al had a market capitalisation of CA$364.09m.
Where are Healwell Al shares listed?
Here are the trading details for Healwell Al:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: AIDX
What kind of share is Healwell Al?
Based on an overall assessment of its quality, value and momentum Healwell Al is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Healwell Al share price forecast for 2025?
The analyst consensus target price for shares in Healwell Al is CA$3.66. That is 150.68% above the last closing price of CA$1.46.
Analysts covering Healwell Al currently have a consensus Earnings Per Share (EPS) forecast of -CA$0.09 for the next financial year.
Find out moreWhat is the trend in the Healwell Al share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Healwell Al. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +25.12%.
As of the last closing price of CA$1.46, shares in Healwell Al were trading -12.79% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Healwell Al PE Ratio?
The Healwell Al PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$1.46.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Healwell Al?
We do not have data on Healwell Al's directors